Skip to main content

Apr exports value down 13%

The value of Hong Kong's total exports decreased to $338.3 billion in April, down 13% on the same month last year, the Census & Statistics Department announced today.   The value of imports of goods decreased 11.9% to $374.9 billion for the same period.   A trade deficit of $36.6 billion, or 9.8% of the value of imports, was recorded in April.   Comparing the three-month period ending April with the preceding three months on a seasonally adjusted basis, the value of exports rose 15.4%, while that of imports increased 10.7%.   The Government noted that the value of merchandise exports declined further from a year earlier in April. Exports to the Mainland, the US and the European Union all shrank and exports to other major Asian markets recorded decreases of varying degrees.   Looking ahead, it added that the weakness in the advanced economies will continue to weigh on Hong Kong's export performance, though the expected faster recovery of the Mainland economy should

Vaccine use paper published

The Scientific Committee on Vaccine Preventable Diseases and the Scientific Committee on Emerging & Zoonotic Diseases under the Centre for Health Protection today published the consensus recommendations on the use of BNT162b2 COVID-19 vaccine by Fosun Pharma/BioNTech among the frail elderly in Hong Kong.   The Advisory Panel on COVID-19 Vaccines issued a report last month, advising the Secretary for Food & Health that under the current pandemic situation, the benefits of using BNT162b2 in Hong Kong for people aged 16 or above for active immunisation to prevent COVID-19 outweigh its risk.   Noting that reports of death cases among very frail people following the use of BNT162b2 in some European countries, the advisory panel suggested to collect more information for the Joint Scientific Committee on Emerging & Zoonotic Disease and Scientific Committee on Vaccine Preventable Diseases together with the Expert Advisory Panel to the Chief Executive (JSC-EAP) for examination.   The Department of Health had obtained information from various sources, including overseas health and drug regulatory authorities as well as media reports, for the JSC-EAP to review.   Based on the available information and recommendations from overseas jurisdictions and the World Health Organization as of January, the JSC-EAP considered that there is currently no evidence suggestive of any unexpected or untoward increase in mortality in frail elderly following the use of BNT162b2.   There is also no clear evidence suggesting the reported deaths were due to the use of that vaccine.   Adverse events following immunisation is defined as any untoward medical occurrence which follows immunisation and it does not necessarily have a causal relationship with the use of the vaccine.   For the very frail elderly, any mild adverse event from pharmaceutical products including vaccines might worsen their original disease or condition.   For elderly people with severe frailty, especially those at the most extreme age groups such as those above 85 years old, the benefits and risks of receiving BNT162b2 should be evaluated separately by attending clinicians and such clinical assessment should be exercised with greater caution.   As stated in the consensus interim recommendation published last month, any individual who is experiencing acute febrile diseases should delay their vaccination and this recommendation applies to the use of BNT162b2 among frail elderly.   Additionally, the JSC-EAP considered that reports and data about the safety and efficacy of BNT162b2 should be closely monitored.   The benefit-risk balance should also be evaluated again when more information on rare adverse events and long-term side effects from mass vaccination programmes continue to emerge.   Click here for the consensus document.
http://dlvr.it/RsY5QR

Popular posts from this blog

Legal officer changes proposed

The Government has proposed to amend the law to allow legal officers of the Department of Justice to be appointed as a senior counsel.   At a media session after attending a Legislative Council meeting today, Secretary for Justice Teresa Cheng explained the rationale behind the Government's proposal.   She said: “Why is it that my colleagues in the Department of Justice - who by their qualifications are solicitors but are actually arguing very well and very efficiently with great eloquence and efficacy in the Court of Final Appeal - are not being recognised when they are actually even better than their counterparts? That has always been something that sometimes troubles me.   “And for that reason, I have always been thinking about how we are going to overcome that problem.   “Now, what really triggers my determination to take this further forward is when one of our Deputy Directors of Public Prosecutions, Vinci Lam, took silk on May 29.   “That really showed that the form

124 COVID-19 cases reported

The Centre for Health Protection today said it is investigating 124 additional COVID-19 cases. More cases were detected in Kwai Chung Estate. There are also more than 70 preliminary positive cases.   Among the newly reported cases, 33 are related to Kwai Chung Estate, bringing the total number of positive and preliminary positive cases in the estate to 276.   One more positive case was found after an earlier confirmed case occurred at Glory Court, Tsuen Wan Garden, both of them live in units 5 but on two different floors. The centre has co-ordinated with related government departments and conducted an inspection today.    It was preliminarily considered that vertical transmission of virus via pipes is involved.   The centre will issue quarantine orders to residents of unit 5 on all floors of the building who resided there during the incubation period of the relevant cases and transfer them to a quarantine facility.   As it is possible that virus might be ejected from the open

Govt explains vaccine surplus plan

The Government said it will discuss with the drug manufacturers on how to handle the expected surplus COVID-19 vaccine doses concerning this year's COVID-19 Vaccination Programme.   It made the statement in response to a media report which claimed that Hong Kong will throw away millions of COVID-19 vaccine doses due to low vaccination rate.   The Government noted that as at May 24, out of the two million odd doses each of the Sinovac and BioNTech vaccine which have arrived in Hong Kong, there are 1.05 million and 840,000 unused doses.   It pointed out that the BioNTech vaccine needs to be stored in an ultra-low temperature setting and the vaccines have a relatively short expiry date from the date of manufacture which is around three to four months after arrival in Hong Kong. The vaccines now in storage will expire in mid-August.   The Government observed that the public's demand for the BioNTech vaccine has gradually become sluggish recently.   Compared with the daily